Clinical Research Directory

Inclusion Criteria: * Previous pathologic confirmation of a tumor treated with radiation to the brain completed at least 6 months prior to the start of planned reirradiation, except for patients with tumors that are routinely diagnosed without biopsy, including germinoma and optic pathway glioma; patients with a history of cranial irradiation for leukemia are eligible * Patient must have received one and only one previous course of radiation to the brain, delivered at 1.5 - 2.5 Gy/fraction, one fraction per day * Multidisciplinary evaluation of the patient must be performed with a consensus recommendation for reirradiation * Patient may not receive concurrent chemotherapy with reirradiation, other than temozolomide or bevacizumab given at the discretion of the treating neuro-oncologist * Patient must have imaging findings within the last 3 months consistent with recurrent disease in the brain; pathologic diagnosis of recurrence is not required * Patient may undergo surgical resection prior to reirradiation * Dose-volume histogram data and cross-sectional imaging from previous radiation must be obtained; electronic dosimetry records in Digital Imaging and Communications in Medicine (DICOM) format from previous radiation are strongly preferred * Signed informed consent by patient and/or parents or legal guardian * Lansky/Karnofsky performance status score of 50-100 Exclusion Criteria: * Patients with recurrent diffuse intrinsic pontine glioma (DIPG) * Pregnancy